- Home
- Products
- Customized FluoroAb™
- LYPD3
- Anti-LYPD3 MAb (Clone 2)-iFluor® 350 Succinimidyl Ester
Anti-LYPD3 MAb (Clone 2)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS296)
This product is comprised of an Anti-LYPD3 antibody (Clone 2) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- LYPD3
- Alternative Names
- LYPD3; C4.4A; LY6/PLAUR domain containing 3
- Overview
- Anti-LYPD3 antibody (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Carlumab-iFluor 647 (CAT#: ADC-FL-315)
- Anti-VEGFA MAb (Clone 15)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1554)
- Anti-IGF1R MAb (Clone 3)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5226)
- Anti-HGF MAb (Clone 10)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8962)
- Anti-MET MAb (Clone 21)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2952)
- Anti-CD40 MAb (Clone 13)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13487)
- Margetuximab-iFluor 594 (CAT#: ADC-FL-1358)
- Anti-GPC3 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4711)
- Anti-DLL4 Therapeutic Antibody-PBlue (CAT#: ADC-FL-1116)
- Eldelumab-Bodipy FL (CAT#: ADC-FL-1074)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS296. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-110 | Anti-LYPD3-lysine-toxophore ADC-1 | lysine | toxophore loading |
| ADC-W-561 | Anti-LYPD3-auristatin ADC | Auristatin | |
| ADC-W-111 | Anti-LYPD3-lysine-toxophore ADC-2 | lysine | toxophore loading |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.